Silencing and Un-silencing of Tetracycline-Controlled Genes in Neurons
2007

Gene Silencing in Neurons

publication Evidence: moderate

Author Information

Author(s): Zhu Peixin, Aller M. Isabel, Baron Udo, Bausen Melanie, Herb Jan, Sawinski Jürgen, Cetin Ali, Osten Pavel, Nelson Mark L., Kügler Sebastian, Seeburg Peter H., Sprengel Rolf, Hasan Mazahir T.

Primary Institution: Max Planck Institute for Medical Research, Heidelberg, Germany

Hypothesis

What causes the controversial performance of tetracycline-controlled gene expression in mammalian neurons?

Conclusion

Stable integration of Ptet can become functionally silenced in most neurons if it is inactive during development, but high transactivator levels can overcome this silencing.

Supporting Evidence

  • Stable integration of Ptet becomes functionally silenced in the majority of neurons when inactive during development.
  • Long-term, high transactivator levels can often overcome integration-induced Ptet gene silencing.
  • Basal Ptet activity yields permissive conditions for faster activation/re-activation.

Takeaway

Scientists studied how certain genes can be turned on and off in brain cells, finding that if a gene is not used during development, it can become 'silent' and hard to turn back on later.

Methodology

The study involved using transgenic mice with specific gene expression controls and measuring gene activity through various methods including luciferase assays and immunohistochemistry.

Limitations

The study may not account for all factors influencing gene silencing and activation in different neuronal populations.

Digital Object Identifier (DOI)

10.1371/journal.pone.0000533

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication